People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Health Care, Healthtech, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroPace Inc | — | Other Health Care | Series C | $208.6M | $1.5B | 2011 |
| Avertix Medical, Inc. | — | Healthtech | Series B | $121.3M | $4.7M | 2019 |
| Svelte Medical Systems Inc | — | Biotechnology | Series C | $113.1M | $163.7M | 2009 |
| eNeura, INC. | — | Other Technology | Series A | $53.6M | $14.2M | 2012 |
| Neuralieve, Inc. | — | Other Health Care | Series A | $11.4M | $151.0M | 2009 |
| TETmedical, Inc. | — | Other Health Care | Seed | $2.5M | $17.4M | 2023 |
David Fischell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Fischell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Fischell | 4 | 6 |
| Frank Fischer | 2 | 5 |
| Robert E. Fischell | 2 | 5 |
| Phillip D. Torrence | 2 | 4 |
| David R. Fischell | 2 | 3 |
| Terese Baker | 2 | 2 |
| Somu Subramaniam | 1 | 17 |
| Rishi Gupta | 1 | 12 |
| Nael Kassar | 1 | 11 |
| Annette Campbell-White | 1 | 11 |
| Jonathan Silverstein | 1 | 10 |
| David Rosen | 1 | 10 |
| James Blair | 1 | 8 |
| Greg Garfield | 1 | 8 |
| ROBERT CROCE | 1 | 7 |
| Robert Kline | 1 | 6 |
| Renee Ryan | 1 | 6 |
| R. Jacob Vogelstein | 1 | 6 |
| John Conley | 1 | 5 |
| Benjamin Pless | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.